Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SARS-CoV-2 Antibody Levels in Neonatal Cord Blood and Maternal Serum Following Coronavirus Vaccination During Pregnancy
TCTR20250714004Completed
- Sponsor
- NA
- Start
- May 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by NA. Primary endpoints: SARS-CoV-2 antibody levels in neonatal cord blood and SARS-CoV-2 antibody levels in maternal serum at delivery. Started May 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20250714004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250714004.